Delcath Systems, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the ...
Targeted Oncology1d
Organ-Sparing TMLI Enhances AML Transplant Outcomes
Anthony Stein, MD, assessed total marrow and lymphoid irradiation with post-transplant cyclophosphamide in patients with ...
StockNews.com Initiates Coverage on CASI Pharmaceuticals (NASDAQ:CASI)
StockNews.com started coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research report report published on Tuesday. The brokerage issued a hold rating on the biotechnology ...
The Bulletin3dOpinion
Commentary: How federally funded research saved my son’s sight — and his life
If you want to make this country great, imagine the strength of a nation whose children have been fought for and know they ...
Yahoo Finance2d
Delcath Systems, Inc. (DCTH)
After hours: March 11 at 7:20:47 PM EDT Loading Chart for DCTH ...
Yahoo Finance4d
Delcath Systems, Inc. (DCTH)
After hours: 4:20:00 p.m. EDT Loading Chart for DCTH ...